NOVEL METHOD AND COMPOSITION COMPRISING IL-2 AND A TISSUE- OR ORGAN-SPECIFIC TARGETING MOIETY Flanders Institute for Biotechnology
The invention relates to a pharmaceutical composition for use in a method of treating, preventing and/or reducing ageing, said composition comprising IL-2 and a targeting moiety specific for a tissue or organ of a subject, such as the brain and wherein the ageing is neurological ageing. Also provided are methods for treating, preventing and/or reducing ageing (e.g. neurological ageing) or cognitive decline, said methods comprising administration of a pharmaceutical composition as defined herein.